Research programme: human monoclonal antibodies - Amgen/Lexicon
Alternative Names: Human monoclonal antibodies research programme - Abgenix/LexiconLatest Information Update: 01 May 2007
At a glance
- Originator Amgen; Lexicon Genetics
- Developer Amgen; Lexicon Pharmaceuticals
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation
Most Recent Events
- 01 May 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 01 May 2007 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 03 Apr 2006 Abgenix has been acquired and merged into Amgen